
Sad that @EHA_Hematology #CRTH2024 is coming to an end this week but looking forward to 2025 - please consider applying to join us!

Myeloma Clinician Scientist 🔬💊👩🏻🔬👩🏻⚕️

Sad that @EHA_Hematology #CRTH2024 is coming to an end this week but looking forward to 2025 - please consider applying to join us!

What is @EHA_Hematology Clinical Research Training in #Hematology (CRTH)? #CRTH provides early-career researchers with a unique, 9-month long training and mentoring experience. The CRTH 2025 call for applications is open until August 30, 2024 search.app/383eipgfnc8AdXth7

📣 Our Early Career Advancement Fellowships are officially open for applications! 📣 These awards will support the brightest and best early career blood cancer researchers as they begin their journey to independence. Full details on our website bloodcancer.org.uk/research/…


From learning new #clinicaltrial skills to developing your own research project, #EHA Clinical Research Training in Hematology (#CRTH) is a chance to advance your #hematology career. Hear from C Lecat, past CRTH scholar about her experience 👇 Learn more: eha.fyi/CRTH25

There will be opportunities to contribute to T- cell directed therapy service expansion and be involved in / lead clinical research - working with a great team! Feel free to free to contact me for further information or apply at link above.

We are looking for a new consultant colleague (10 PA, substantive NHS post). Great opportunity for anyone with an interest in myeloma who wants to join an academic centre. royalmarsden.nhs.uk/current-…

Great new tool for patients presented by @MyelomaEurope at #EMN2024

Great session at #EMN2024 from patient organisations @IMFmyeloma and @MyelomaEurope

Not sure if you can submit an abstract and join #EHA2024? If you are under 36, you may qualify for a travel or participation grant. Grant applications are available during regular abstract submission and close on March 1, 2024. Submit an abstract: eha.fyi/EHA2024_abstracts

Presenting the work of Dr Yigen Li from my lab @ICR_London at #ASH2023

Should have added @kennycairns @Orla_McCourt 😊


Exciting initial HRQoL data from the FiTNEss trial. @CTRUmyeloma @profBigG @profghjackson @LeedsCTRU

Protein shake! Amazing talk by @apwiita on Proteomics to ID new MM targets. Poss source of biomarkers / classification of disease. Can use protein “Surfaceome” to ID new targets /protein conformation differences specific to MM plasma cells for targeting #mmsm #IMS23 @UCSFCancer
